CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- 4 Open-market sale CHIEF OPERATING OFFICER sold 4,517 shares at an average $43.64 ($197,129)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 1,234 shares at an average $43.59 ($53,794)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 3,480 shares at an average $43.62 ($151,805)
- 4 Open-market sale SVP, FINANCE & CAO sold 906 shares at an average $43.59 ($39,492)
- 4 Open-market sale CHIEF TECHNICAL OPS OFFICER sold 759 shares at $41.66 ($31,617)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 758 shares at $41.66 ($31,575)
- 4 Open-market sale EXEC. VP AND CLO sold 835 shares at $41.66 ($34,783)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 731 shares at $41.66 ($30,451)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 858 shares at $41.66 ($35,741)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 2,065 shares at $41.66 ($86,020)
- 4 Open-market sale SVP, FINANCE & CAO sold 706 shares at $41.66 ($29,409)
- 4 Grant or award SVP, FINANCE & CAO acquired 14,000 shares (grant or award)
- 4 Grant or award CHIEF TECHNICAL OPS OFFICER acquired 17,710 shares (grant or award)
- 4 Grant or award EXEC. VP AND CLO acquired 17,000 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 19,500 shares (grant or award)
- 4 Grant or award CHIEF BUSINESS OFFICER acquired 18,000 shares (grant or award)
- 4 Grant or award CHIEF OPERATING OFFICER acquired 26,000 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 71,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
Page 12 of 31 · 618 filings